4D Molecular Therapeutics, Inc.
Biotechnology company · Emeryville, California, United States · Nasdaq: FDMT
4D Molecular Therapeutics, Inc. is a biotechnology company headquartered in Emeryville, California, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker FDMT. It has reported private securities offerings to the US SEC, most recently $90 million sold in a notice filed in 2018.
4D Molecular Therapeutics at a glance
What does 4D Molecular Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $90 million sold (2018).
Frequently asked questions about 4D Molecular Therapeutics
Where is 4D Molecular Therapeutics headquartered?
4D Molecular Therapeutics, Inc. is headquartered in Emeryville, California, United States.
What does 4D Molecular Therapeutics do?
4D Molecular Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is 4D Molecular Therapeutics a public company?
Yes. 4D Molecular Therapeutics, Inc. trades on Nasdaq under the ticker FDMT.
When was 4D Molecular Therapeutics founded?
The earliest incorporation on record for 4D Molecular Therapeutics, Inc. is in 2015, according to public company registers.
Similar companies
- Kyverna Therapeutics, Inc.Emeryville, California, United States
- Gritstone bio, Inc.Emeryville, California, United States
- Eureka Therapeutics, Inc.Emeryville, California, United States
- Topaz Biosciences, Inc.Emeryville, California, United States
- Metagenomi Therapeutics, Inc.Emeryville, California, United States
- Safelyyou Inc.Emeryville, California, United States
- Octant IncEmeryville, California, United States
- Milagen, Inc.Emeryville, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences